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Abstract
Nitric oxide (NO) is an endogenous antibacterial agent produced by immune cells in response to
pathogens. Herein, the NO fluxes necessary to reduce bacterial adhesion of different bacteria (S.
aureus, methicillin-resistant S. aureus, S. epidermidis, E. faecalis, E. coli, and P. aeruginosa) were
investigated to ascertain the sensitivity of these bacteria to NO. S-nitrosothiol NO donor-modified
xerogels were selected as a model NO-release surface due to their extended NO-release kinetics
relative to other NO donor systems. The xerogels were coated with poly(vinyl chloride) (PVC) to
achieve consistent surface energy between NO-releasing and control substrates. Fibrinogen was
pre-adsorbed to these materials to more accurately mimic conditions encountered in blood and
promote bacteria adhesion. Nitric oxide fluxes ranging from 20–50 pmol cm−2 s−1 universally
inhibited the bacterial adhesion by >80% for each strain studied. Maximum bacteria killing
activity (reduced viability by 85–98%) was observed at the greatest NO payload (1700 nmol
cm−2).
1. Introduction
Implanted medical devices are employed increasingly in hospital settings to treat and/or
monitor a multitude of health conditions. While some devices are utilized for hours or days
(e.g., catheters), some reside in a patient’s body for years (e.g., pacemakers, orthopedic
screws). Regardless of implant time or location, device-associated infections impact almost
all medical implants.1 For example, central venous catheters (CVCs) result in >80,000
bloodstream infections annually with significant consequences (e.g., rigorous and expensive
treatment).2, 3
Implant-associated infections are the result of protein adsorption, bacterial adhesion, and
subsequent colonization.4–6 The colonized bacteria excrete an extracellular matrix offering
protection from the immune response and external treatment (e.g., antibiotics) in the form of
a biofilm. Eradication of biofilm bacteria requires significantly greater antibiotic
concentrations than killing of planktonic bacteria.7 Without complete eradication, bacteria
can proliferate and recolonize the material.8 With the emergence of antibiotic-resistant
strains, device removal or replacement is often the only possible treatment option.9, 10
Fortunately, the prevention and killing of adhered bacteria have been shown to decrease the
incidence of implant-associated infections.4
To date, many clinically approved devices do not adequately prevent bacterial adhesion and
biofilm formation.11 The development of anti-bacterial materials is thus important for
addressing device-associated infections. This goal has been pursued through the
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biomaterials that actively release an antimicrobial agent.1 Passive antibacterial materials
(e.g., polyethyelene glycol, quaternary ammonium-modified interfaces)12–14 have a limited
sphere of influence as they only affect bacteria in direct contact with the surface. Often, this
sphere/antibacterial efficacy is reduced upon protein adsorption.1 In contrast, materials that
actively release antibacterial agents can impact bacteria both in contact with and in the
vicinity of a surface. Antibacterial agents that have been effectively loaded into polymeric
biomaterials for subsequent release include antibiotics,15, 16 antibodies,17 silver ions,18 and
nitric oxide (NO).19, 20
Nitric oxide, a reactive, diatomic radical produced by immune cells by the body response to
pathogens,21, 22 has received considerable attention as an antibacterial agent due to its
localized action and broad spectrum activity. Materials capable of storing and releasing NO
have been the focus of intense research for the goal of reducing bacterial adhesion and
implant-associated infections. 23, 24 Surface NO release has been shown to influence both
bacterial adhesion and biofilm formation.25, 26 Nablo and Schoenfisch reported that NO
fluxes ≥30 pmol cm−2 s−1 inhibited Pseudomonas aeruginosa adhesion by 85%.20 Charville
et al. subsequently examined the reduction of bacterial adhesion due to NO flux in the
presence of adsorbed fibrinogen (Fg) to better mimic in vivo conditions.19 While the
adsorbed fibrinogen enhanced bacterial adhesion, a NO flux-dependent reduction of
bacterial adhesion was still observed for both Gram-positive and negative bacteria.
The potential to both reduce adhesion and kill adhered bacteria sets NO apart from other
antibacterial agents. Hetrick and Schoenfisch previously reported the killing efficacy of NO
for P. aeruginosa as a function of NO payload.27 Herein, we further these studies by
investigating the NO fluxes necessary to inhibit bacterial adhesion and reduce the viability
of adhered bacteria as a function of bacteria species and class. Such studies are critical for
understanding the clinical potential of NO-releasing interfaces.
2. Materials and Methods
3-Mercaptopropyltrimethoxysilane (MPTMS) was purchased from Gelest (Morrisville, PA).
Methyltrimethoxysilane (MTMOS), poly(vinyl chloride) (PVC), and diethylenetriamine
pentaacetic acid (DTPA) were purchased from Fluka (Buchs, Switzerland). Human
fibrinogen (Fg; >95% clottable, >95% purity) was obtained from Enzyme Research
Laboratories (Southbend, IN). Fibrinogen was stored at −80 °C, thawed at 37 °C for 10 min,
and maintained at ambient temperature. Staphylococcus aureus (ATCC #29213),
methicillin-resistant Staphylococcus aureus (MRSA; ATCC #33591), Staphylococcus
epidermidis (ATCC #35983), Enterococcus faecalis (ATCC #29212), Pseudomonas
aeruginosa (ATCC #19143), and Escherichia coli (ATCC #53323) were obtained from
American Type Culture Collection (Manassas, VA). Nitric oxide was purchased from
Praxair (Danbury, CT). Nitric oxide calibration gas (26.39 ppm; balance nitrogen), nitrogen,
and argon were purchased from Airgas National Welders (Raleigh, NC).
2.1. Xerogel synthesis
Mercaptosilane-modified xerogels (40% (v/v) MPTMS/MTMOS) were prepared on glass
substrates as described previously by mixing 800 μL ethanol (EtOH), 480 μL MTMOS, 320
μL MPTMS, and 25 μL hydrochloric acid (HCl; 0.5 M).28 The solution was vortexed for 1
h, and allowed to age for 4 h at room temperature. Glass microscope slides (9 × 25 mm2)
were sonicated in EtOH for 30 min, then dried under a stream of nitrogen. A 30 μL aliquot
of the xerogel mixture was cast onto each glass slide and dried overnight under ambient
conditions, then cured in a 70 °C oven for 2 d. The resulting xerogel-modified substrates
were stored at room temperature until further use.
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The MPTMS-containing xerogels were nitrosated to form S-nitrosothiol NO donors by
incubating the substrates in 0.5 M HCl containing a 10x molar excess of nitrite (versus
moles of thiol) and 100 μM DTPA for 3 h.28 Of note, xerogels were kept on ice and shielded
from light during nitrosation to prevent pre-mature NO donor decomposition. Slides were
washed with 100 μM DTPA and stored at −20 °C in the dark until further use. Non-
nitrosated xerogels were used as control (non-NO-releasing) interfaces.
2.3. Poly(vinyl chloride) coating
Poly(vinyl chloride) (1.0 g) was dissolved in tetrahydrofuran (THF; 10 mL). Approximately
300 μL of the PVC/THF solution was spin-coated onto control and S-nitrosothiol–modified
xerogels using a CHEMAT Technology KW-4A Precision Spin-Coater (Northridge, CA) set
to spin at 3.0 krpm. The quality of the coating process was evaluated using light microscopy.
Only those PVC-coated samples without visual fault (e.g., cracking, unusual roughness
features) were used for further studies. The PVC-coated xerogels were stored at −20 °C until
further use.
2.4. Bacterial adhesion
Bacteria were cultured in tryptic soy broth (TSB) at 37 °C, pelleted by centrifugation, rinsed
with sterile water, resuspended in a solution of phosphate buffered saline (PBS; 10 mM, pH
7.4) with 15% (v/v) glycerol, and stored at −80 °C. Secondary cultures were grown from an
aliquot of the frozen stock in TSB overnight. A 1 mL portion of this solution was inoculated
into 100 mL of TSB and grown to ~108 colony-forming units (CFU) per mL as measured by
optical density. The resulting culture was collected by centrifugation (4500 g, 5 min) and
resuspended in PBS.
To reach the desired NO flux, the PVC-coated NO-releasing xerogels were incubated at 37
°C for 0.5–96 h. The substrates were then immersed in 4 mL of a 20 μg/mL solution of Fg in
PBS (pH 7.4) for 90 min at 37 °C (gentle shaking). A concentration of 20 μg/mL Fg enabled
the formation of a protein monolayer (and not protein agglomerates and/or multilayers) on
the PVC.29 The PVC-coated xerogels were then removed from the Fg solution and
immediately immersed in 4 mL of a bacterial suspension (108 CFU/mL) at 37 °C for 60 min.
2.5. Optical microscopy for imaging of adhered bacteria
Following incubation in the bacterial suspension, the PVC-coated xerogel substrates were
removed, immersed in water to remove loosely adhered bacteria, and dried with a stream of
air. Adhered bacteria were imaged via phase contrast optical microscopy at 20x
magnification using a Zeiss Axiovert 200 Inverted Microscope equipped with a Zeiss
Axiocam. At least three different PVC-coated xerogel substrates were imaged for each NO
flux. Five randomly selected regions on each slide were used to calculate an average
bacterial surface coverage. The images were digitally processed by thresholding to make
opaque cells contrast sharply with the transparent xerogel substrates. The relative surface
coverage was translated from the number of dark pixels in the thresholded image, and
normalized relative to controls (i.e., non-NO-releasing) which were scored as 1.
2.6. Adhered bacterial viability
Upon removal from the bacterial suspension, the substrates were immersed in sterile water
to remove loosely adhered bacteria, and then transferred to 4 mL of PBS for 0, 6, 12, or 24
h. The PBS was supplemented with 0.5% (v/v) TSB for S. aureus, MRSA, S. epidermidis,
and E. coli strains to ensure viability for 24 h. After the appropriate incubation period, the
slides were gently rinsed with sterile water to remove loosely adhered bacteria. The PVC
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layer was then peeled away from the xerogel substrate, placed into 1 mL of PBS, and then
sonicated for 15 min at 40 kHz to remove adhered bacteria.17, 27 Removal of bacteria cells
via sonication was confirmed by optical microscopy of the PVC layer. After sonication, the
solution was serially diluted and plated onto tryptic soy agar (TSA) nutrient plates
(incubated at 37 °C). Bacterial viability was determined by counting the colonies on each
plate using an IUL Flash & Go (Neutec Group, Farmingdale, NY). This plate counting
method has an inherent limit of detection of 2.5 × 103 CFU/mL.30
2.7. Contact angle measurements
Static water contact angle measurements of fibrinogen-adsorbed PVC-coated, PVC-coated,
and bare control and NO-releasing xerogels were acquired with a KSV Instruments Cam 200
Optical Contact Angle Meter (Helsinki, Finland). Three droplets (~10 μL) of 18.2 MΩ water
were placed onto the substrate (n ≥ 3) at room temperature with enumeration of the receding
angle.
2.8. Nitric oxide release measurements
Nitric oxide release was measured continuously in PBS using a Sievers 280i
Chemiluminescence Nitric Oxide Analyzer (NOA) (Boulder, CO).31 Calibration of the NOA
was performed for each analysis using ambient air passed through a Sievers NO zero filter
and a 26.39 ppm NO gas standard (balance N2). To ensure measurement reproducibility,
NO-releasing xerogels were immersed in 30 mL of deoxygenated PBS shielded from light.
Liberated NO was carried to the analyzer in a nitrogen stream (200 mL min−1). Temperature
control was maintained through the use of a water bath at 37 °C.
3. Results and Discussion
3.1. Material characterization
S-Nitrosothiol NO-donor-modified xerogels28 were chosen for this study to enable
investigation of a large range of NO-surface fluxes. S-Nitrosothiols provide longer NO-
release durations compared to N-diazeniumdiolate NO donors when incorporated within
xerogel films.20, 28, 32, 33 The desired NO flux was achieved by pre-incubating the xerogels
at 37 °C at set periods. To control for deviations in surface energy of the control and
nitrosated xerogels (as measured by contact angles of 70 ± 1 and 54 ± 3°, respectively) that
would impact bacterial adhesion,28 the xerogels were modified with a PVC coating. The
PVC coatings easily foul with protein and bacteria, and therefore allow for systematic
examination of bacterial adhesion.34 Contact angles for controls and NO-releasing xerogels
were identical (~89 ± 4°) following PVC-modification. Neither delamination nor
degradation of the PVC or xerogel layers was observed for the PVC-coated xerogels
regardless of incubation period.
Initial experiments revealed that S. aureus, MRSA, and E. coli did not readily adhere to
control PVC-coated substrates (<0.10 relative surface coverage). Low absolute adhesion for
these strains would make accurate measurements of the relative adhesion to NO-releasing
substrates difficult due to the error inherent in the optical microscopy evaluation. To
enhance bacterial adhesion and mimic in vivo biofouling more closely, PVC-coated slides
were pre-incubated in fibrinogen (Fg) solutions prior to bacteria exposure. Contact angles of
Fg-adsorbed PVC-coated control and NO-releasing xerogels were both 55 ± 5° (decreased
from 89°), confirming Fg adsorption and the expected surface alteration. Charville et al.
previously reported that NO-release does not influence Fg adsorption onto PVC interfaces.19
Soaking the Fg-adsorbed surfaces in PBS for 24 h had no effect on the contact angle
indicating that the Fg layer is not weakly bound.
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The NO-release properties of the bare and PVC-coated S-nitrosothiol xerogels are provided
in Table 1. As expected, the PVC topcoat did not significantly alter the NO-release
properties of the xerogels since the NO release is thermally triggered and NO readily
diffuses through PVC.28, 34 The substrates released NO for at least 14 d at low NO fluxes
(e.g., 0.16 pmol cm−2 s−1). The average NO flux employed for the bacteria studies ranged
from 0.5–50 pmol cm−2 s−1, with 50 pmol cm−2 s−1 selected as the greatest flux due to
unpreventable loss of NO during the pre-incubation of the xerogels in Fg prior to bacteria
exposure. Prior to immersion in bacteria solutions, the greatest NO flux measured for the
PVC-coated NO-releasing xerogels was 260 pmol cm−2 s−1 (Table 1). The NO flux changes
by a large degree initially due to the pseudo first-order NO-release kinetics common for S-
nitrosothiol-modified xerogels.28
3.2. Bacterial adhesion
The degree of bacterial adhesion to PVC-coated control and NO-releasing xerogels was
examined using large bacteria concentrations (~108 CFU/mL). Although such
concentrations are not biologically relevant for most implants, a starting concentration of
~108 CFU/mL of bacteria allowed for larger absolute surface coverage for all bacterial
strains, a requirement for studying differences in bacterial adhesion via optical microscopy.
Using the NO-release data provided in Table 1, S-nitrosothiol-modified xerogels were pre-
incubated at 37 °C for periods between 30 min and 4 d to achieve a wide-range of average
NO fluxes over the subsequent 1 h bacteria assay (0.50 ± 0.08, 1.0 ± 0.1, 2.5 ± 0.4, 5.0 ±
0.8, 10 ± 2, 20 ± 4, 35 ± 5, and 50 ± 10 pmol cm−2 s−1). The resulting NO fluxes allowed for
investigation of NO’s anti-bacterial adhesion properties. Increased error was noted for the
larger NO fluxes due to the pseudo first-order NO-release kinetics that rapidly change at
early time points (e.g., NO flux is reduced by >50% between 1 and 5 h).
Based on prior adhesion results,19, 20, 27 we predicted a negative correlation between
bacterial adhesion and NO flux. Indeed, a NO flux-dependent decrease in bacterial adhesion
was observed for all six bacterial strains investigated (Figure 1) relative to controls (with 1.0
indicating identical adhesion to the control substrates). S. aureus, MRSA, E. faecalis, and E.
coli showed a greater susceptibility to NO from 0–20 pmol cm−2 s−1 with little to no
additional reduction in bacterial adhesion (surface coverage) at increased NO fluxes. This
maximum plateau in reduced adhesion corroborates a previous report by Nablo and
Schoenfisch where NO release resulted in a large initial reduction in bacterial adhesion but
was followed by little additional effect beyond a certain NO flux threshold.20 In contrast, P.
aeruginosa and S. epidermidis required greater NO fluxes to inhibit adhesion by 50% (20
and 35 pmol cm−2 s−1, respectively) and 80% (35 and 50 pmol cm−2 s−1, respectively).
While increased NO fluxes were necessary to reduce adhesion for these particular strains,
the NO release still decreased adhesion by >80%, analogous to the relative inhibition
observed for other strains (Table 2).
Linear regressions of the relative bacteria adhesion (measured as surface coverage) as a
function of NO flux were performed from 0–20 pmol cm−2 s−1 to compare the relative
susceptibility of each bacterial strain to NO (Table 2). This range was chosen because all
strains showed a linear (r2 = 0.91–0.98) reduction in adhesion, allowing for direct
comparison between strains. This linearity only held true until ~80% reduction in bacterial
adhesion. All of the strains studied except S. epidermidis were characterized as having
similar linear regression slopes, ranging from −0.036 to −0.043 relative bacterial adhesion/
pmol cm−2 s−1 of NO. Slight variations in slope were independent of the class of bacteria
(Gram-positive or Gram-negative) and likely an attribute of the broad-spectrum activity of
NO arising from multiple mechanisms of action on bacteria (e.g., nitrosative and oxidative
stress).35 In our study, S. epidermidis was the only bacterium with a relatively low
susceptibility to NO with respect to bacterial adhesion (slope of −0.017). Charville et al.
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reported similar behavior when investigating the role of Fg and NO release on bacterial
adhesion,19 S. epidermidis is indeed unique in that it has Fg-binding proteins such as serine-
aspartate repeat G (SdrG) present on its surface.36 While S. aureus also has Fg-binding
proteins (e.g., Clumping Factor A),37 the dissociation constant (KD) of SdrG is two orders of
magnitude lower than Clumping Factor A, indicating a significantly increased binding
strength.38 The large affinity of SdrG to Fg may decrease the susceptibility of S. epidermidis
to the anti-adhesive effects of surface-derived NO. Despite the relatively low efficacy of NO
in preventing S. epidermidis adhesion, NO release at fluxes >20 pmol cm−2 s−1 further
diminished the bacterial surface coverage with an 81% reduction in adhesion compared to
control surfaces for a flux of 50 pmol cm−2 s−1. Greater NO fluxes may further inhibit S.
epidermidis adhesion; however, the maximum average NO flux that could be achieved over
the 1 h study using the S-nitrosothiol-modified xerogels was limited to 50 pmol cm−2 s−1.
3.3. Bacteria surface viability
Reduction of bacterial adhesion is a crucial initial step in the design of antibacterial
interfaces that prevent colonization on implantable devices. However, the most effective
antibacterial surfaces should both reduce bacterial adhesion and kill any bacteria that do
adhere to minimize bacteria proliferation and biofilm formation.39 While our prior work
with P. aeruginosa demonstrated reduced viability of adhered bacteria to a NO-releasing
interface in a dose-dependent manner,27 this study was limited to one bacteria strain. As
such, the effect of NO release on the viability of adhered bacteria was not systematically
investigated with respect to bacterial strains. Based on prior literature,19, 27, 40–42 we
hypothesized that the viability of adhered bacteria would be reduced in a NO dose-
dependent manner regardless of strain due to NO’s broad spectrum action and modes of
killing.1, 43, 44 The effect of total NO payload (i.e., cumulative NO release) over time was
thus investigated against as a function of bacteria strain to evaluate the potential for surface-
derived NO to kill adhered bacteria broadly. After the 1 h bacterial adhesion assay, the
substrates were incubated for 0, 6, 12, or 24 h in PBS (E. faecalis and P. aeruginosa) or 0.5%
TSB in PBS (S. aureus, MRSA, S. epidermidis, and E. coli) to provide bacteriostatic
conditions. As not all bacteria survived in PBS for 24 h due to lack of nutrients, the 0.5%
TSB was required for some strains to preserve bacterial viability. The viability was
confirmed by quantifying planktonic bacteria of each strain in PBS and 0.5% TSB in PBS.
The average time-dependent NO fluxes and payloads, provided in Table 3, ranged from 0.5–
50 pmol cm−2 s−1 and 38–1700 nmol cm−2, respectively, over the 24 h of incubation. Since
the NO release followed pseudo first-order kinetics, substrates with an initial average NO
flux of 20, 35, and 50 pmol cm−2 s−1 delivered 48, 53, and 77% of their 24 h NO payload in
the first 6 h, respectively (Table 3). In contrast, substrates with lower initial average NO
fluxes (e.g., 0.5 and 1.0 pmol cm−2 s−1) delivered NO in a more sustained manner, with only
~25% of the 24 h NO payload released during the first 6 h.
To ensure that only bacteria adhered to the PVC-coated xerogel and not to the sides or back
of the glass substrates were enumerated, the outer PVC layer was physically removed from
the glass slide and sonicated. These bacteria were then plated onto TSA plates and
enumerated to quantify viable bacteria.27 Optical microscopy confirmed that this sonication
step removed >93% of the adhered bacteria and thus the viability quantification was an
accurate measurement. Relative adhered bacterial viability was calculated as a function of
time by dividing the viable bacteria concentration at x = 6, 12, or 24 h by the viable bacteria
at t = 0 for a given bacteria strain and NO flux (Equation 1). A relative viability of 1 would
thus indicate that the NO release
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had zero effect on the killing of adhered bacteria. Of note, the viability of bacteria adhered
to control substrates was constant (negligible death) between the 0 and 24 h time points.
To ascertain whether NO was solely preventing adhesion or also killing adhered bacteria
during the 1 h adhesion period, relative adhesion and relative viability were compared for
the S. aureus and E. coli strains (Figure 2). The relative surface coverage as determined by
microscopy and relative adhesion of viable bacteria were generally comparable at all NO
fluxes after a 1 h exposure. For example, S. aureus relative viability at substrates with an
average NO flux of 50 pmol cm−2 s−1 was ~0.15 that of control substrates, in line with the
~0.10 relative adhesion observed with microscopy (Figure 2A). The positive agreement
between surface coverage and viable bacteria counts immediately following the adhesion
assay indicates that surface NO release initially only influences bacterial adhesion and not
adhered bacterial cell death.
While NO works primarily to prevent bacterial adhesion initially (during ~1 h), NO
uniquely kills adherent bacteria at longer exposure times making it an unusual antibacterial
agent. This time-dependent viability of bacteria adhered to the NO-releasing surfaces is
provided in Figure 3 and Tables 4, 5, and 6 for 6, 12, and 24 h NO-release conditions. The
reduction in adhered bacteria viability was dependent on NO payload for all strains, albeit
time dependent. For example, nearly all strains (MRSA, S. epidermidis, E. faecalis, E. coli,
and P. aeruginosa) exhibited reduced viability at NO-releasing substrates at 6 h.
Unexpectedly, the viability of adhered S. aureus was minimal prior to the 24 h time point
(Table 6). As indicated by the data, this strain of S. aureus may require a minimal NO
threshold to induce killing. S. aureus is known to resist NO via metabolic activities and as
such killing may require greater NO concentrations, although it is uncertain why MRSA was
not affected in this manner.45
The lowest 24 h NO payload investigated (38 nmol cm−2) eradicated 17–34% of the adhered
bacteria regardless of bacteria species. Conversely, the greatest NO payload (1700 nm cm−2)
caused the maximal reduction in adhered bacteria viability at 24 h exposure to substrates
with an initial NO flux of 50 pmol cm−2 s−1 were 85, 85, 86, 92, 95, and 98% for S. aureus,
MRSA, S. epidermidis, E. faecalis, E. coli, and P. aeruginosa, respectively (Table 6).
Therefore, substrates with an initial NO flux of 50 pmol cm−2 s−1 delivering a payload of
1700 nmol cm−2 over 24 h inhibited adhesion of all strains by >80% with concomitant
eradication of ≥85% of the adhered bacteria. After the 1 h adhesion period, the initial NO
flux of 50 pmol cm−2 s−1 resulted in a bacterial viability of 5 × 105 – 1 × 106 CFU cm−2 for
each of the six strains examined. As such, enough viable bacteria were present that could
still colonize the material.8 Of note, significantly larger concentrations of bacteria were
employed in this study compared to what might be encountered clinically.
The NO payloads necessary to decrease the adhered bacteria viability by 50 and 80% after
24 h are provided in Table 7. Cumulative NO release levels of 66–240 and 240–1700 nmol
cm−2 were required to reduce adhered bacteria viability by 50 and 80%, respectively. P.
aeruginosa and E. coli were the most vulnerable strains with respect to NO-based toxicity, a
result that was previously reported for planktonic bacteria.46 Importantly, the amount of
bacteria killed is not proportional to the amount of NO released.
The rate of the total NO delivery also affected bacteria viability. While the cumulative NO
payloads of xerogels with initial NO fluxes of 2.5 and 0.5 pmol cm−2 s−1 were
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approximately equivalent at 6 and 24 h, respectively (38–40 nmol cm−2, Table 3), E. faecalis
viability at 6 h to surfaces with the greater initial NO flux (0.42 ± 0.05) was significantly
lower than the viability at 24 h to surfaces with an initial NO flux of 0.5 pmol cm−2 s−1
(0.83 ± 0.07). This data suggests the bactericidal properties of NO-releasing surfaces are
dependent on the NO payload, rate of delivery, and duration of NO release.
While the NO payloads used in this study were bactericidal to multiple strains, the
cytotoxicity to mammalian cells represents an important consideration for future therapeutic
potential. Nablo and Schoenfisch previously reported that NO-releasing PVC-coated
xerogels were only slightly cytotoxic to L929 fibroblasts after 24 h incubation after an initial
NO flux of ~50 pmol cm−2 s−1.47 These previous results reveal that NO fluxes capable of
greatly reducing bacterial adhesion and viability typically avoid cytotoxic effects against
mammalian cells.
4. Conclusion
Herein, the adhesion of S. aureus, MRSA, S. epidermidis, E. faecalis, E. coli, and P.
aeruginosa at pre-adsorbed Fg interfaces was investigated to understand the influence of NO
release adhered bacteria viability. An average NO flux from 20–50 pmol cm−2 s−1 over a 1 h
exposure period decreased bacterial adhesion by >80% regardless of bacterial strain. With
the exception of S. epidermidis, the adhesion of Gram-positive and Gram-negative bacteria
were equally affected by surface-derived NO release. S. epidermidis required significantly
greater NO fluxes (50 pmol cm−2 s−1) to inhibit adhesion to the level observed for other
strands (>80%) relative to control xerogels. S. epidermidis’ Fg-binding membrane protein
affinity to the adsorbed Fg likely influences both general adhesion and NO’s decreased anti-
adhesive properties. We are currently testing this hypothesis with other S. epidermidis
strains. Regardless of bacteria species, the number of viable bacteria adhered to the NO-
releasing substrates decreases in a dose-dependent manner, but only after a set residence
time. In other words, NO is not biocidal immediately upon surface adhesion. Future
experiments must optimize the NO concentration (flux) and NO-release kinetics to
maximize both antibacterial adhesion and biocidal activity, but minimize toxicity to
mammalian cells. Of course, the ultimate test will require thorough in vivo evaluation with
biofilm and infection models.25
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The NO flux-dependent relative adhesion of A) S. aureus, B) MRSA, C) S. epidermidis, D)
E. faecalis, E) E. coli, and F) P. aeruginosa to pre-adsorbed Fg PVC-coated xerogels after 1
h of exposure. A relative adhesion of 1.0 represents the adhesion of the strain to control (i.e.,
non-NO-releasing) substrates. Data are mean ± standard deviation.
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The NO flux-dependent relative adhesion (open) and viability (filled) immediately following
the 1 h adhesion period for A) S. aureus and B) E. coli to pre-adsorbed Fg PVC-coated
xerogels. A relative adhesion or relative viability of 1.0 represents the adhesion or viability
of the strain to control (i.e., non-NO-releasing) substrates. Data are mean ± standard error of
the mean.
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Relative viability of S. aureus, MRSA, S. epidermidis, E. faecalis, E. coli, and P. aeruginosa
at 3 different initial NO fluxes (1.0, 10, and 50 pmol cm−2 s−1) at incubation times of 6, 12,
and 24 h.
Nichols and Schoenfisch Page 13

























Nichols and Schoenfisch Page 14
Table 1
Nitric oxide-release properties of bare and PVC-coated 40% S-nitrosothiol-modified xerogels. Data are mean
± standard deviation for at least three separately prepared substrates.
NO-release properties 40% MPTMS/MTMOS xerogel PVC-coated 40% MPTMS/MTMOS xerogel
tmax (min)a 1.1 ± 0.2 1.2 ± 0.2
[NO]max (pmol cm−2 s−1) 290 ± 70 260 ± 60
[NO]1 h (pmol cm−2 s−1) 64 ± 10 58 ± 8
[NO]5 h (pmol cm−2 s−1) 26 ± 5 22 ± 4
[NO]12 h (pmol cm−2 s−1) 9 ± 1 8 ± 1
[NO]24 h (pmol cm−2 s−1) 3.4 ± 0.5 3.2 ± 0.5
[NO]48 h (pmol cm−2 s−1) 1.2 ± 0.1 1.1 ± 0.1
[NO]96 h (pmol cm−2 s−1) 0.5 ± 0.1 0.5 ± 0.1
Total NO (μmol cm−2) 2.6 ± 0.4 2.5 ± 0.3
a
Time to reach maximum NO flux
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Table 3
Nitric oxide payloads (nmol cm−2) at 6, 12, and 24 h after the 1 h adhesion assay for initial average NO fluxes
from 0.5–50 pmol cm−2 s−1 NO fluxes examined. Data are mean ± standard deviation.
Initial NO flux (pmol cm−2 s−1)
NO payload (nmol cm−2)
6 h 12 h 24 h
0.5 9.5 ± 0.8 19 ± 2 38 ± 2
1.0 17 ± 2 33 ± 3 66 ± 4
2.5 40 ± 3 72 ± 5 105 ± 9
5.0 90 ± 9 140 ± 10 240 ± 20
10 150 ± 20 250 ± 20 370 ± 20
20 270 ± 20 410 ± 30 550 ± 50
35 390 ± 50 560 ± 50 740 ± 60
50 1300 ± 200 1500 ± 200 1700 ± 200
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Table 7
The required surface-derived total NO payload to decrease adhered bacteria viability by 50 and 80% after 24 h
incubation in bacteriostatic media. Data are mean ± standard deviation.
NO payload that reduced adhered bacteria viability by
50% (nmol cm−2)
NO payload that reduced adhered bacteria viability by
80% (nmol cm−2)
S. aureus 240 ± 20 1700 ± 200
MRSA 105 ± 9 550 ± 50
S. epidermidis 105 ± 9 550 ± 50
E. faecalis 66 ± 4 740 ± 60
E. coli 66 ± 4 240 ± 20
P. aeruginosa 66 ± 4 240 ± 20
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